In a chest CT pulmonary angiogram with suboptimal pulmonary artery opacification limiting evaluation but no large central filling defects, is this finding concerning for pulmonary embolism?

Suboptimal CTPA with No Large Central PE: Clinical Significance

A CTPA report stating "suboptimal opacification of pulmonary arteries limits evaluation, otherwise no large central filling defects are identified" is NOT definitively concerning for PE, but requires clinical correlation and may necessitate further evaluation depending on pretest probability. This finding essentially means the study successfully ruled out large central PE but cannot reliably exclude smaller peripheral emboli 1, 2.

Understanding the Report

The radiologist is communicating two key points:

1. Technical limitation: Inadequate contrast opacification prevents confident evaluation of smaller pulmonary arteries (typically subsegmental and some segmental branches)
2. Partial reassurance: Large, clinically significant central PE (main, lobar, and proximal segmental arteries) has been excluded

Suboptimal opacification most commonly occurs due to:

• Poor contrast bolus timing (accounts for ~80% of cases) 3
• Patient factors: Valsalva maneuver during scanning, severe heart failure, patent foramen ovale causing right-to-left shunting 4
• Body habitus or technical factors 5

Clinical Decision-Making Algorithm

Step 1: Assess Clinical Pretest Probability

If LOW clinical probability (Wells score <2 or Geneva score <3):

• A negative CTPA for central PE is adequate to exclude clinically significant PE 1
• The three-month thromboembolic risk is acceptably low (0.3-1.5%) 1
• No further testing needed in most cases
• Consider D-dimer if not already done; negative D-dimer further supports withholding anticoagulation

If INTERMEDIATE or HIGH clinical probability:

• Suboptimal study creates diagnostic uncertainty
• Further evaluation is warranted 1, 6

Step 2: Consider Lower Extremity Venous Ultrasound

Perform compression ultrasound of lower extremities to look for proximal DVT 1, 6:

• If proximal DVT present: Treat as PE equivalent—anticoagulation indicated regardless of CTPA findings
• If negative: Significantly reduces likelihood of clinically significant PE
• This approach is particularly useful when repeat CTPA would be problematic (renal insufficiency, contrast allergy)

Step 3: Evaluate for Repeat Imaging vs. Clinical Management

Consider repeat CTPA with optimized technique if:

• High clinical probability persists
• Symptoms are severe or worsening
• Lower extremity ultrasound is negative but clinical suspicion remains high
• Patient has risk factors for extension (active cancer, hospitalization, pregnancy) 7

Optimize repeat CTPA by:

• Ensuring adequate scan delay (15-30 seconds depending on cardiac function) 8
• Having patient perform deep inspiration and hold breath 8
• Using adequate contrast volume and injection rate 2

Step 4: Alternative Diagnostic Strategies

V/Q scanning can be considered but has very low yield after suboptimal CTPA:

• Only 2.5% positive rate for PE following suboptimal CTPA (compared to 10.7% baseline) 3
• Most suboptimal CTPAs successfully rule out central PE, making subsequent V/Q scanning of limited value
• May be reasonable if patient has contraindication to repeat contrast administration

Critical Caveats

The Subsegmental PE Dilemma

Even with optimal CTPA, isolated subsegmental PE remains controversial 7:

• Inter-observer agreement is poor for subsegmental defects 9
• 27% of subsegmental "PE" diagnoses by community radiologists are indeterminate, and 15% are false positives 9
• Clinical significance is questionable—many may not require treatment 1, 7

If subsegmental PE is suspected on suboptimal study, consider:

• Serial lower extremity ultrasound over 2 weeks as alternative to anticoagulation (if no severe symptoms or risk factors for extension) 7
• Anticoagulation if: multiple defects, high clinical probability, elevated D-dimer, active cancer, reduced mobility, pregnancy, or low cardiopulmonary reserve 7

Common Pitfalls to Avoid

1. Don't assume suboptimal = positive: Suboptimal opacification does NOT indicate PE is present—it indicates diagnostic uncertainty for peripheral vessels only 10

2. Don't ignore alternative diagnoses: 28% of suboptimal CTPAs show alternative explanations for symptoms (pneumonia most common at 59%) 3

3. Recognize false-positive risks: Motion artifact is the most common cause of false-positive PE diagnosis (50% of false positives), especially in subsegmental vessels 9, 10

4. Consider contrast threshold: Diagnostic CTPA requires pulmonary artery opacification ≥210 Hounsfield units 11. Studies with lower opacification have unacceptably high false-negative and indeterminate rates 9

Practical Recommendation

For most patients with suboptimal CTPA showing no central PE:

• Low pretest probability → No further testing; no anticoagulation
• Intermediate/high pretest probability → Obtain lower extremity ultrasound
  • If positive → Anticoagulate
  • If negative + symptoms improving → Clinical observation
  • If negative + symptoms severe/worsening → Repeat optimized CTPA

The key principle: Clinicians should be particularly cautious with discordance between clinical judgment and imaging results 1. When high clinical suspicion persists despite negative or suboptimal imaging, additional testing is justified to avoid missing clinically significant PE.